🔎 Trials Near Me

Akèy › Kansè Poumon ki pa ti selil › New Hampshire › Manchester

Etid klinik pou Kansè Poumon ki pa ti selil nan Manchester, NH

5 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Manchester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • Solinsky Center for Cancer Care, Manchester
  • New Hampshire Oncology Hematology PA-Concord, Concord · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04267848

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Solinsky Center for Cancer Care, Manchester
  • New Hampshire Oncology Hematology PA-Concord, Concord · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Solinsky Center for Cancer Care, Manchester
  • New Hampshire Oncology Hematology PA-Concord, Concord · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2/3
  • Solinsky Center for Cancer Care, Manchester
  • New Hampshire Oncology Hematology PA-Concord, Concord · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Solinsky Center for Cancer Care, Manchester
  • New Hampshire Oncology Hematology PA-Concord, Concord · 15 mi lwen
18 Minutes · Tout sèks · Mizajou May 5, 2026 · NCT06031688

Etid Kansè Poumon ki pa ti selil nan lòt vil

Lòt etid nan Manchester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.